On the path to 2025: understanding the Alzheimer’s disease continuumPaul Aisen, Bruno Dubois, Jeffrey L. Cummings et al.|Alzheimer s Research & Therapy|2017Cited by 559
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trialHilkka Soininen, Noel Ellison, Alina Solomon et al.|The Lancet Neurology|2017Cited by 244
Inflammatory biomarkers in Alzheimer's disease plasmaAngharad R. Morgan, B. Paul Morgan, Samuel Touchard et al.|Alzheimer s & Dementia|2019Cited by 207
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkersIris E. Jansen, Pablo García‐González, Fahri Küçükali et al.|Acta Neuropathologica|2022Cited by 138
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF‐AD studyRebecca G. Smith, Katie Lunnon, Ehsan Pishva et al.|Alzheimer s & Dementia|2024Cited by 16